Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 17:32:48 UTC |
---|
Update Date | 2021-09-26 23:12:55 UTC |
---|
HMDB ID | HMDB0256918 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline |
---|
Description | 2-[(3-phenyl-5,6-dihydro-2H-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline belongs to the class of organic compounds known as tetrahydroisoquinolines. These are tetrahydrogenated isoquinoline derivatives. Based on a literature review very few articles have been published on 2-[(3-phenyl-5,6-dihydro-2H-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline. This compound has been identified in human blood as reported by (PMID: 31557052 ). 2-[(3-phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | C(C1CN=C(NO1)C1=CC=CC=C1)N1CCC2=CC=CC=C2C1 InChI=1S/C19H21N3O/c1-2-7-16(8-3-1)19-20-12-18(23-21-19)14-22-11-10-15-6-4-5-9-17(15)13-22/h1-9,18H,10-14H2,(H,20,21) |
---|
Synonyms | Value | Source |
---|
3-Phenyl-6-(1,2,3,4-tetrahydro-2-isoquinolinyl)methyl-4H-5,6-dihydro-1,2,4-oxadiazine | MeSH | 3-Phenyl-6-(1,2,3,4-tetrahydro-2-isoquinolyl)methyl-4H-5,6-dihydro-1,2,4-oxadiazine | MeSH | PTHIQDO | MeSH |
|
---|
Chemical Formula | C19H21N3O |
---|
Average Molecular Weight | 307.397 |
---|
Monoisotopic Molecular Weight | 307.168462308 |
---|
IUPAC Name | 2-[(3-phenyl-5,6-dihydro-2H-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline |
---|
Traditional Name | 2-[(3-phenyl-5,6-dihydro-2H-1,2,4-oxadiazin-6-yl)methyl]-3,4-dihydro-1H-isoquinoline |
---|
CAS Registry Number | Not Available |
---|
SMILES | C(C1CN=C(NO1)C1=CC=CC=C1)N1CCC2=CC=CC=C2C1 |
---|
InChI Identifier | InChI=1S/C19H21N3O/c1-2-7-16(8-3-1)19-20-12-18(23-21-19)14-22-11-10-15-6-4-5-9-17(15)13-22/h1-9,18H,10-14H2,(H,20,21) |
---|
InChI Key | GWAKPCRBHTWEKQ-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as tetrahydroisoquinolines. These are tetrahydrogenated isoquinoline derivatives. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Tetrahydroisoquinolines |
---|
Sub Class | Not Available |
---|
Direct Parent | Tetrahydroisoquinolines |
---|
Alternative Parents | |
---|
Substituents | - Tetrahydroisoquinoline
- Aralkylamine
- Imidolactam
- Benzenoid
- Monocyclic benzene moiety
- Tertiary aliphatic amine
- Tertiary amine
- Oxacycle
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Amidine
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline | C(C1CN=C(NO1)C1=CC=CC=C1)N1CCC2=CC=CC=C2C1 | 3699.9 | Standard polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline | C(C1CN=C(NO1)C1=CC=CC=C1)N1CCC2=CC=CC=C2C1 | 2595.7 | Standard non polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline | C(C1CN=C(NO1)C1=CC=CC=C1)N1CCC2=CC=CC=C2C1 | 2981.3 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TMS,isomer #1 | C[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 2793.3 | Semi standard non polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TMS,isomer #1 | C[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 2538.1 | Standard non polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TMS,isomer #1 | C[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 3737.6 | Standard polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 2951.0 | Semi standard non polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 2765.5 | Standard non polar | 33892256 | 2-[(3-Phenyl-5,6-dihydro-2h-1,2,4-oxadiazin-6-yl)methyl]-1,2,3,4-tetrahydroisoquinoline,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1OC(CN2CCC3=CC=CC=C3C2)CN=C1C1=CC=CC=C1 | 3794.6 | Standard polar | 33892256 |
|
---|